Dr. Andrea Low is Clinical Associate Professor at Duke-National University of Singapore and Head of Department, Rheumatology and Immunology, Singapore General Hospital (Singhealth). Her clinical and research interest is in systemic sclerosis (SSc). She spear-headed the nation-wide collaborative SSc research workgroup dedicated to advancing clinical care and research in SSc, and established the Systemic Sclerosis Cohort in Singapore (SCORE) cohort since 2008. She is recipient of the Clinician Scientist Award for her work in SSc. She is convenor of the Asia Pacific League of Associations of Rheumatology (APLAR) SSc special interest group, spearheading the APLAR SSc incident cohort (APSSIC). She is member of the Scleroderma Clinical Trials Consortium, contributing to the education sub-committee. She led her Department to recognition as the APLAR Centre of Excellence (since 2017). In partnership with Janssen, their multi-disciplinary Cardiology, Respiratory and Rheumatology pulmonary hypertension team at Singhealth is recognised as a Centre of Excellence for Pulmonary Hypertension that serves as a regional reference centre for training and management of all causes of pulmonary hypertension.